Literature DB >> 7240394

Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies.

D B Budzko, D F Jelinek, B W Wilcke.   

Abstract

Approximately 7% of the sera tested to determine the presence of rubella-specific antibodies by the hemagglutination inhibition test demonstrated abnormal patterns of reactivity, rendering the test unreadable. Another 3% of sera were shown to have false-positive titers as high as 1:128. When these abnormally reacting and false-positive sera were heated at 56 degrees C for 30 min after chemical treatment they always converted to negative, indicating the absence of specific rubella hemagglutination-inhibiting antibody. These results were confirmed by fractionation of the sera after sucrose gradient centrifugation. It was established that manifestation of these nonspecific results was dependent on the concentration of Ca2+ or Mn2+. The heat-labile inhibitor(s) responsible for abnormal and false-positive reactions was found not to be complement. This inhibitor(s) was detected in the light fractions of sera and when added to negative sera was capable of reproducing the abnormal patterns of reactivity. These results emphasize the necessity of heating sera for the rubella hemagglutination inhibition test after the chemical removal of nonspecific inhibitors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240394      PMCID: PMC273895          DOI: 10.1128/jcm.13.5.818-823.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  The role of aggregated gamma-globulins in the anticomplementary activity of human and animal sera.

Authors:  L H FROMMHAGEN; H FUDENBERG
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

2.  Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.

Authors:  B J Mills; N R Cooper
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

3.  Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies.

Authors:  T Vesikari; A Vaheri
Journal:  Br Med J       Date:  1968-01-27

4.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

6.  Rubella hemagglutination-inhibition test: false-positive reactions in sera contaminated with bacteria.

Authors:  J B Campbell; M Romach; M L Ellins
Journal:  J Clin Microbiol       Date:  1976-11       Impact factor: 5.948

7.  Use of sodium polyanetholesulfonate-CaCl2 for removal of serum nonspecific inhibitors of rubella hemagglutination: comparison with other polyanion-divalent cation combinations.

Authors:  M L Ellins; J B Campbell
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

8.  Rubella antibody titer. The significance of low-titered rubella antibodies.

Authors:  R E Harris; P A Jordon; G R Monif
Journal:  Obstet Gynecol       Date:  1978-08       Impact factor: 7.661

9.  Positive rubella titers in pregnancy: a question of validity.

Authors:  J A Hall; E R Wills; K Hall; J W Pearson
Journal:  Obstet Gynecol       Date:  1979-08       Impact factor: 7.661

10.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.

Authors:  N R Cooper; F C Jensen; R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

  10 in total
  8 in total

1.  Determination of immune status to measles, rubella, and varicella-zoster viruses among medical students: assessment of historical information.

Authors:  D L Murray; M A Lynch
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

2.  Single radial hemolysis test for rubella immunity and recent infection.

Authors:  P W Neumann; J M Weber
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

3.  Multicenter evaluation of a 1-h enzyme-linked immunosorbent assay for rubella serology.

Authors:  W L Boteler; K J Barnes; E Buimovici-Klein; A J O'Beirne
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

4.  Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus.

Authors:  J M Meegan; B K Evans; D M Horstmann
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

5.  Removal of nonspecific hemagglutination inhibitors, immunoglobulin G, and immunoglobulin A with streptococcal cells and its application to the rubella hemagglutination inhibition test.

Authors:  K Kawano; Y Minamishima
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.

Authors:  M Zrein; J H Joncas; L Pedneault; L Robillard; R J Dwyer; M Lacroix
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

7.  Fluorescence immunoassay and passive latex agglutination as alternatives to hemagglutination inhibition for determining rubella immune status.

Authors:  S L Fayram; A Nakasone; S Aarnaes; M Zartarian; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

8.  Detection of bacterial-reactive natural IgM antibodies in desert bighorn sheep populations.

Authors:  Brian S Dugovich; Melanie J Peel; Amy L Palmer; Ryszard A Zielke; Aleksandra E Sikora; Brianna R Beechler; Anna E Jolles; Clinton W Epps; Brian P Dolan
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.